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Computational analysis of 
stochastic heterogeneity in PCR 
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The polymerase chain reaction (PCR) is one of the most widely used techniques in molecular biology. 
In combination with High Throughput Sequencing (HTS), PCR is widely used to quantify transcript 
abundance for RNA-seq, and in the context of analysis of T and B cell receptor repertoires. In 
this study, we combine DNA barcoding with HTS to quantify PCR output from individual target 
molecules. We develop computational tools that simulate both the PCR branching process itself, and 
the subsequent subsampling which typically occurs during HTS sequencing. We explore the influence 
of different types of heterogeneity on sequencing output, and compare them to experimental results 
where the efficiency of amplification is measured by barcodes uniquely identifying each molecule of 
starting template. Our results demonstrate that the PCR process introduces substantial amplification 
heterogeneity, independent of primer sequence and bulk experimental conditions. This heterogeneity 
can be attributed both to inherited differences between different template DNA molecules, and the 
inherent stochasticity of the PCR process. The results demonstrate that PCR heterogeneity arises 
even when reaction and substrate conditions are kept as constant as possible, and therefore single 
molecule barcoding is essential in order to derive reproducible quantitative results from any protocol 
combining PCR with HTS.
The efficiency of a PCR reaction is known to vary widely, depending on many different factors. These 
include the properties of the primers1–3, the sequence to be amplified4, in particular the GC content5,6, as 
well as the reaction conditions and type of polymerase. If one wishes to quantify the amount of a given 
template by PCR (qPCR) the general approach is to compare an unknown sample to a dilution series of 
standards, on the assumption that all variables remain the same between sample and standard and hence 
PCR efficiency remains constant.
The introduction of high throughput sequencing (HTS)7,8, in which many DNA molecules are 
sequenced individually in parallel, allows the possibility of quantifying many initial target molecules 
simultaneously by counting the number of times the sequence for each molecule occurs in a sequence 
run. This approach forms the basis for RNA-seq, in which transcript abundance is measured by sequenc-
ing cDNA libraries, and counting the number of sequences mapping to each transcript. An extension of 
this approach is the analysis of the antigen-specific receptor repertoire by sequencing cDNA or genomic 
samples of B or T lymphocytes, and counting the number of times each different receptor is identified9. 
Most current parallel sequencing technologies require nanomolar amounts of starting material (typically 
>1010 molecules), even when the output of the reaction may only be in the order of 107 molecules (for 
example the Illumina MiSeq). In order to achieve this amount of starting material some degree of PCR 
amplification is usually required. This is especially true when the amount of starting material may be 
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extremely small, for example in the case of single cell RNA-seq10. The reproducibility of the PCR ampli-
fication process therefore becomes a key factor for accurate quantification.
The use of molecular barcodes provides one approach to dealing with single molecule quantification 
and mitigating the effects of PCR heterogeneity. A library of diverse short DNA sequences (barcodes or 
tags) are introduced into the molecules to be analysed at an early step in the protocol, in such a way 
that each target molecule incorporates a different tag which remains associated with it throughout the 
amplification protocol. The barcodes can be introduced during a reverse transcription step, or by ligation. 
For instance, Miner et al.11 and McCloskey et al.12 both ligate nucleotide sequences to uniquely label 
initial DNA target molecules to identify sequencing redundancy as well as using batch stamps to identify 
sequencing contamination from other samples. In the work of Casbon et al.13 degenerate base regions 
are ligated to each DNA fragment to assess whether observed differences between sequence reads are 
true variants or sequence error. Kivioja et al.14 apply a similar unique molecular identifier technique to 
human karyotyping. Mamedov et al.15 and Shugay et al.16 use barcodes to provide PCR and sequencing 
error correction of TCR repertoires.
In this study we use molecular barcoding to investigate the extent of variation in PCR amplification 
on a single molecule basis. In order to rigorously assess the possible sources of this heterogeneity we 
develop an efficient PCR simulator, which incorporates both amplification and sampling heterogeneity, 
with which to compare our experimental results. The PCR amplification is an example of a branching 
process, and although there has been considerable theoretical work on such processes, the complexity 
of heterogeneous branching processes makes analytical modelling challenging in most realistic exam-
ples17–19. Detailed models of the physical parameters involved in the PCR cycles have been developed, to 
answer questions about the probability of replication in an individual cycle or the evolution of the pop-
ulation over a number of cycles20–24. Additionally mathematical models have been used to investigate the 
error profile in PCR protocols25 or the presence of non-targeted product through non-specific priming26. 
An increase in computing power has made it feasible to develop PCR simulations using realistic numbers 
of starting molecules, with reasonable run times. The model we describe includes both an amplification 
step and a sampling step to simulate the typical workflow of an RNA-seq or repertoire sequencing exper-
iment. These computational tools can distinguish heterogeneity which derives simply from the sampling 
process itself (modelled as a zero truncated Poisson process) from stochastic variation in each step of the 
PCR reaction and inherited variation which may arise from differences between different DNA molecules 
within the reaction. Our study therefore highlights the potential pitfalls in quantitative analysis of DNA 
or RNA abundance involving a PCR amplification step, and provides a computational framework which 
can be used to analyse barcoded PCR data, and identify and quantify the sources of heterogeneity.
Methods
Ethics. This study was approved by the joint UCL/University College London Hospitals NHS Trust 
Human Research Ethics Committee and was carried out in accordance with relevant guidelines and 
regulations. Written informed consent was obtained from all participants (University College Hospital 
06/Q0502/92).
Sample collection. 5 ml of healthy adult volunteer blood was drawn into Tempus Blood RNA tubes (Life 
Technologies) and RNA was extracted using the Tempus RNA isolation kit (Life Technologies). Residual 
DNA was removed using the TURBO DNase kit, and globin mRNA was depleted using GLOBINclear 
(both Life Technologies).
The KT2 T cell clone was a gift of Prof. A. Lanzavecchia (Institute for Research in Biomedicine, 
Bellinzona, Switzerland). The clone was grown as described27. RNA was isolated using the RNeasy Mini 
Kit (Qiagen). RNA was treated with RQ1 DNase (Promega) following manufacturer’s instructions to 
remove any residual genomic DNA.
Two different protocols were used to amplify and then sequence the T cell receptor chains. All primers 
are from Sigma-Aldrich and sequences can be found in Table 1.
Protocol using single strand ligation (Protocol A). The DNAse treated RNA was reverse transcribed using 
oligos complimentary to the 5′ region of the TCR constant regions TRAC and TRBC (α RC2 and β RC2). 
The mastermix for the reverse transcription was added to the RNA in two stages (molarities for both 
mastermixes relate to the final volume of 30\mu l). 11 μ l of DNase treated RNA were mixed with 0.5 μ M 
α RC2, 0.5 μ M β RC2 and 0.5 mM of each dNTP (Invitrogen) to total 19.5 μ l, and then incubated at 65 °C 
for 5 min and cooled rapidly on ice for > 1 min. 1× FS buffer (Invitrogen), 5 mM DTT (Invitrogen), 
30–60 units RNasin Ribonuclease Inhibitor (Promega) and 300 units SuperScript III reverse transcriptase 
(Life Technologies) were added before incubation at 55 °C for 30 min in a total volume of 30 μ l. 40 mM 
NaOH were added to remove any remaining RNA and the sample was incubated at 70 °C for 15 min. 
0.5 M sodium acetate were added to adjust the pH before the cDNA reverse transcription product was 
purified using MinElute columns (Qiagen).
The single stranded cDNA was ligated, using T4 RNA ligase (NEB) to a 5′ phosphorylated 3′ blocked 
oligonucleotide (T4DNA_6N_SP2 in Table 1) containing 6 base pairs of random nucleotide barcode and 
the Illumina sequencing primer SP2. 5 μ l of cDNA were mixed with 1x T4 RNA ligase buffer (NEB), 
1mM hexammine cobalt chloride, 1.5 μ M BSA, 0.33mM ATP (NEB), 0.33 μ M ligation oligo and 20 units 
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T4 RNA ligase 1 (NEB). The ligation was carried out at 16° C for 23 hours followed by a 10 minute heat 
inactivation step at 65° C. 70 μ l water were added to the ligation mix before samples were purified at a 1:1 
ratio with AMPure XP SPRI beads (BeckmanCoulter) following manufacturer’s instructions and eluted 
in 30–35 μ l water. A second strand was then synthesised, priming from the ligated SP2 sequence. The 
AMPure bead purified ligation product was incubated with 1x HF buffer, 0.5 μ M SP2 primer, 0.5 mM of 
dNTPs and 1 unit of Phusion polymerase in a 50 μ l reaction at 98 °C for 3 min, lowered slowly (1 °C/sec) 
to 80 °C, held at 80 °C for 10 sec, lowered slowly (1 °C/sec) to 58 °C and held at 58 °C for 30 sec. After the 
final extension at 72 °C for 1 min, the product was again purified on AMPure beads.
An additional random six base pair barcode was added to the 3′ end with a third strand synthesis. 
The conditions for third strand synthesis were identical to second strand, but an using an oligonucleo-
tide complimentary to the constant region, and an extension containing the random barcode, and the 
Illumina SP1 sequencing primer (SP1-6N-I-X-α RC1, or SP1-6N-I-X-β RC1). A diagram showing the 
structure of the DNA at this point is shown in Fig. 1a (top).
The barcoded TCR samples were then amplified in two different consecutive PCR reactions. In the 
first PCR the P5 and P7 adapters required for Illumina sequencing, and an index for multiplex sequenc-
ing were added with primers P5-SP1 and P7-LX. The PCR conditions used were 1x HF buffer, 0.5 μ M 
P5-SP1, 0.5 μ M P7-LX, 0.5 mM dNTPs and 1 unit Phusion; initial cycle: 98 °C for 3 min, slowly ramped 
to 69 °C for 15 sec and 1 min at 72°; cycle 2–4: 98 °C for 10 sec and 72 °C for 1 min; final cycle: 72 °C for 
5 min. After bead purification the samples were amplified in a second PCR (1x HF buffer, 0.5 μ M P5s 
(details below), 0.5 μ M P7 (details below), 0.5 mM dNTPs and 1 unit of Phusion); initial cycle 98 °C for 
3 min; cycle 1–24: 98 °C for 10 sec, 69 °C for 15 sec, 72 °C for 40 sec; final cycle: 72 °C for 5 min. PCR2 
products were bead purified and eluted in 30 μ l water.
Protocol A is represented schematically in Supplementary Fig. 5.
Protocol using fixed V region primer (Protocol B). DNAse treated RNA isolated from the KT2 clone was 
reverse transcribed using oligos complementary to the 5′ region of the TCR β constant region TRBC. The 
oligonucleotides also contained a random 12 base pair barcode, the SP1 Illumina sequencing primer and 
an index for multiplexing. We used two different indices, and each index was placed either next to the SP1 
primer sequence (thus providing a spacer between primer and random barcode; SP1-12N-IX-β RC1.1; 
Protocol B(i)), or adjacent to the constant region sequence (SP1-IX-12N-β RC1.1; Protocol B(ii)). Reverse 
transcription was carried out as in Protocol A.
The cDNA was amplified using a KT2 V region specific primer (VBKT2_1, Table  1) and an oligo-
nucleotide complimentary to the Illumina Sequencing Primer SP1. PCR conditions were 1x HF buffer, 
2.5 μ M primers, 0.5 mM dNTPs and 1 unity Phusion; initial cycle 98 °C for 3 min; cycle 1–24: 98 °C for 
10 sec, 69 °C for 15 sec, 72 °C for 40 sec; final cycle: 72 °C for 5 min. PCR products were bead purified 
and eluted in 30 μ l water. The P5, P7 and multiplex index elements were added in 4 additional rounds 
of PCR as described above.
α RC2 GAGTCTCTCAGCTGGTACACG
β RC2 ACACAGCGACCTCGGGTGGGAA
T4DNA_6N_SP2 [Phos]NNNNNNAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC[SpcC3]
α RC1 ACGGCAGGGTCAGGGTTCTGGATAT
β RC1.1 GGTGGGAACACCTTGTTCAGGTCCTC
β RC1.2 GGTGGGAACACGTTTTTCAGGTCCTC
SP1 ACACTCTTTCCCTACACGACGCTCTTCCGATCT
SP2 GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT
SP1-6N-I-X-α RC1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNXXXXXXACGGCAGGGTCAGGGTTCTGGATAT
SP1-6N-I-X-β RC1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNXXXXXXGGTGGGAACACC(G)TTG(T)TTCAGGTCCTC
P5-SP1 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCC
P7-LX CAAGCAGAAGACGGCATACGAGATXXXXXXGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC
P5 AATGATACGGCGACCACCGAGATC
P7 CAAGCAGAAGACGGCATACGAGAT
SP1-IX-12N-β RC1.1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTXXXXXXNNNNTNNNNTNNNGGTGGGAACACCTTGTTCAGGTCCTC
SP1-12N-IX-β RC1.1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNTNNNNTNNNNXXXXXXGGTGGGAACACCTTGTTCAGGTCCTC
VBKT2_1 CTTGGCTATGTGGTCCTTTGC
Table 1. Sequences of primers used. N represents a random (unknown) nucleotide and X represents a 
variable but known nucleotide.
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Library sequencing. Final amplicon products from all sample types were quantified on a Qubit fluorom-
eter (Life Technologies) and sized on a Bioanalyzer (Agilent). Up to 12 samples (at a concentration of 
4 nM) were multiplexed and sequenced on an Illumina MiSeq, using version 2 chemistry 2x 250PE kits.
Data analysis. The FASTQ files produced on the MiSeq were demultiplexed based on the indices added 
through PCR and analysed using a modified version of Decombinator28. Decombinator categorises each 
TCR sequence read by identifying its constituent V gene and J gene, along with the number of nucleotide 
Figure 1. (a) Schematic of the target TCR molecule in Protocols A and B showing the position of the 
barcode for molecular identification and the PCR priming sites. In the T cell receptor portion of the 
molecule, V, D, J and C refer to the Variable, Diversity (β chain only), Joining and Constant regions (not 
to scale). The two alternative possible positions for the barcodes in protocol B(i) and B(ii) are shown in 
brackets. The Illumina sequencing primers, indices to allow for multiplexing of samples, and the Illumina 
adaptor sequences are not shown. (b) Schematic of experimental and computational protocol used to 
sequence and analyse TCRs from isolated RNA. Barcodes (represented here by lower case letters) are 
included in each TCR molecule together with a known sequence (SP2). PCR is then performed to amplify 
the sample. The amplified pool of molecules is diluted and introduced to the sequencer, where a sample of 
molecules will adhere to the flow cell and be sequenced. Repertoire analysis is performed on the sequencing 
data, with the barcodes allowing correction of biased PCR amplification as well as correction of sequencing 
errors. (c) The distribution of observed barcode family size (the number of reads occurring in the sequencer 
output that originate from the same initial target molecule in the sample) in polyclonal TCR sequence data 
(Protocol A) from healthy volunteer T cells. Upper: TCR alpha chain (solid line) and beta chain (dotted 
line) data. Middle: TCR repertoires sequenced at different depths Bottom: TCR repertoires with different 
numbers of observed barcodes, representing the number of initial molecules. (d) The observed barcode 
family size distribution observed in TCR sequence data from a sample of RNA isolated from a T cell clone 
(KT2, responding to tetanus toxoid27). Upper: TCR alpha chain (solid line) and beta chain (dashed line) 
from protocol A. Middle: TCR beta chain data from protocol B, using the oligonucleotide with 6 bp spacer 
between the sequencing primer and the barcode. Bottom: TCR beta chain data from protocol B, using the 
oligonucleotide with the barcode directly next to the sequencing primer.
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deletions from each and the non-germline junctional nucleotides inserted during TCR recombination. 
The five-part Decombinator classifier (DCR) is given by: V gene used, J gene used, number of V dele-
tions, number of J deletions, nucleotides between V and J. The modified version of Decombinator used in 
this study outputs the DCR along with information about the random nucleotide barcode and sequence 
quality in each sequence read.
For analysis of polyclonal TCR sequence data, the Decombinator output is then passed into a PCR- 
and sequencing-error correction script. This script first filters sequence reads to remove those where 
the barcode or sequence quality are poor. It then collects all sequence reads according to their bar-
code, grouping together those DCRs that appear with identical barcodes. If more than one distinct DCR 
appears with the same barcode, we take the DCR with the most copies to be the true sequence with that 
barcode, and the others are aggregated into the largest DCR if they are clearly the product of sequenc-
ing error or discarded otherwise. Next, the set of different barcodes associated with the same DCR is 
considered. Barcodes that are similar and are observed in the context of the same DCR are considered 
to be derived from the same initial molecule and are therefore aggregated. The size of the set of distinct 
barcodes found in the context of the same DCR provides us with a measure of the number of initial 
copies of that T cell receptor present in our sample (the clone size). For this study, we additionally count 
the number of copies of each barcode-DCR combination (the barcode family size) to provide us with 
information about the amplification of the initial molecules.
The structure of the available barcode pool is inferred from the distribution of the number of times 
each barcode is found to have labelled a different cDNA molecule (barcode-labelling events) across all 
experiments in this study. The barcode-labelling events data are fitted by various zero-truncated mixed 
Poisson models using custom functions (found in Supplementary Information), minimised using the 
Optimise function of SciPy in Python. The parameters of the fitted models are used to infer the structure 
of the pool of available barcodes.
PCR simulator. Simulation of labelling, amplification and sequencing of samples of molecules is per-
formed with functions written in Python and available at github.com/uclinfectionimmunity/PCRsim. 
Briefly, at each cycle a molecule has a chance to successfully replicate. The probability of successful 
replication is determined by the PCR model chosen. If replication is successful, nucleotide error is incor-
porated at a given rate by choosing at random whether a given position in the sequence contains error 
and if so which nucleotide is incorporated incorrectly. Molecules to be sequenced are selected at random 
from the amplified pool and sequencing error is incorporated into these molecules similarly.
Results
Heterogeneous amplification efficiency demonstrated by unique molecular barcoding of 
cDNA molecules. We reverse transcribed a sample of TCR RNA from peripheral blood T cells and 
then ligated a primer that contained a unique barcode followed by a sequence corresponding to the 
Illumina SP2 sequencing primer (Protocol A). The individually tagged mixtures of different α and β 
chains were amplified using constant region 3′ primers and a 5′ primer homologous to the Illumina 
SP2 sequence on the ligated oligonucleotide (Fig.  1a top). The resulting amplified PCR reaction was 
diluted and sequenced using the standard Illumina protocol (illustrated diagrammatically in Fig.  1b). 
The number of times each barcode was present in the sequence data was then counted. We refer to all 
sequences that have an identical barcode as a barcode family, and refer to the number of molecules pres-
ent with this barcode as a barcode family size. Although each cDNA molecule was ligated to a different 
barcode, and the starting frequency of each barcode should then be uniform and independent of the 
frequency of the TCR sequence with which it was associated, the observed distribution of barcode family 
sizes in a polyclonal sample was very heterogeneous (Fig. 1c, top). Thus, while the majority of barcode 
families were of size one, some barcodes occurred over 100 times. A similar pattern was observed for 
α and β TCR sequences, indicating that the heterogeneity was not some special feature of the sequence 
being amplified. We repeated this analysis on different polyclonal samples, sequenced at different depths 
(Fig. 1c, middle) and with different numbers of observed barcodes (and therefore different numbers of 
initial target molecule) carried through the protocol (Fig. 1c, bottom). Extensive heterogeneity, varying 
over two orders of magnitude, was observed in each case. Without barcoding, this heterogeneity would 
have a substantial impact on analysis of both the diversity and the structure of the TCR repertoire 
(Supplementary Fig. 2).
One explanation for the observed distribution was the heterogeneous template mixture of cDNAs due 
to the diversity of the TCR repertoire. Although the primers and the primer binding regions were the 
same for all amplified molecules, the intervening sequences were heterogeneous since they represented 
many different TCR sequences. Thus, heterogeneous amplification could reflect differences in target rep-
lication by polymerase. In order to simplify the experimental model, and limit the heterogeneity arising 
from using a complex pool of substrate molecules (a natural TCR repertoire), we labelled and amplified 
a TCR sequence (α and β chain) from a human T cell clone, KT2, which expresses only one T cell 
receptor. As predicted, the vast majority of sequences from these samples were identical. (Supplementary 
Fig. 1). To our surprise the distribution of barcode frequencies was still just as heterogeneous (Fig. 1d, 
top). Thus even under conditions where we were amplifying a single target (namely the KT2 TCR α or β 
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chain), and primer and reaction conditions were identical for all amplified molecules, we still observed a 
difference of two orders of magnitude in the number of molecules derived from single starting template 
cDNA molecules.
We considered two further sources which could potentially contribute to the observed heterogeneity 
in amplification efficiencies. The first was the single-stranded DNA ligation step used in Protocol A 
(Fig. 1a, top). Although this allows a single primer to be used for a heterogeneous mixture of DNAs and 
avoids the need for complex primer multiplexing, it creates a potential for heterogeneity at the end of the 
cDNA template molecule as a result of incomplete reverse transcription of the RNA. A second possible 
cause of heterogeneity are the barcodes themselves. In particular Pan et al.3 have shown that the basepairs 
immediately adjacent to the PCR primer can have a small effect on amplification efficiency.
In order to address the first issue, we performed a further PCR using a fixed primer within the V 
region of the KT2β chain instead of the single stranded ligation step (Protocol B). The unique barcodes 
were introduced during the RT step, and were placed either adjacent to the primer as previously, or sepa-
rated from the primer by a six base pair index region (Fig. 1a, bottom panel). The results of these further 
sets of PCR are shown in Fig. 1d (middle and bottom panels). The omission of the ligation step decreased 
the amount of heterogeneity, although differences in amplification of greater than 10 fold remained.
Barcode family size is not dependent on barcode sequence, barcode clash or non-uniform 
barcode primer frequencies. The heterogeneous amplification observed could hypothetically be 
caused by the barcode itself since the polymerase must amplify the barcode in each cycle. To investigate 
this, we first considered whether barcodes that appear more amplified have a tendency to contain more 
or fewer G or C nucleotides (Fig. 2a). However, there was no obvious relationship between the frequency 
of particular barcodes and their GC content. Furthermore, the frequency of the same barcode in any 
Figure 2. (a) Distribution of GC content of the 12-nucleotide random barcodes by barcode family size 
percentile. Data from a sequence run of healthy volunteer PBMC TCRs. (b)The correlation between the 
barcode family size ranking in any pair of runs for those barcodes that occur in more than one of the 
eight monoclonal KT2 TCR sequencing runs (Protocol A) in this study (R-squared < 0.0003). Ranking is 
ascending, and barcodes that have the same family size in a run are given the same ranking. There is no 
gap introduced in rankings when more than one barcode occupies a particular ranking, as such for small 
barcode family sizes ranking is equivalent to barcode family size. (c) For those pairs of barcodes that appear 
together in any pair of the eight KT2 sequencing runs (Protocol A) in this study, the relationship between 
the difference in barcode family sizes in one run and in the other. R-squared < 0.0004. (d) Position of TCR 
molecules on the flowcell, coloured by barcode family size percentile. Representative example of a single 
frame from one flow cell from a sequencing run in this study.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:14629 | DOi: 10.1038/srep14629
two different sequence runs was uncorrelated (Fig.  2b). A high barcode family size did not therefore 
appear to be the result of a particular barcode sequence or sequence motif. Additionally, to account for 
the fact that the amplification effect might be to do with relative, rather than absolute, barcode ‘fitness’, 
we considered all pairs of barcodes that both appear in any pair of experiments. If the amplification 
was determined by the barcode we would expect, for example, that if barcode A is larger than barcode 
B in experiment 1 then it would also be larger in experiment 2. We found no correlation between the 
frequencies of any two barcodes that appear together in a pair of experiments (Fig.  2c), implying that 
the barcode sequence itself does not determine the efficiency with which each molecule is amplified. 
We also examined whether the observed barcode family size might be an artefact introduced during the 
sequencing reactions, perhaps by heterogeneity in bridge PCR on the flow cell. If this were the case we 
would expect that molecules from large barcode families are located in close proximity on the flow cell. 
However there was no observable relationship between barcode family size and location of molecules on 
the flow cell (one representative frame shown in Fig. 2d).
The barcodes should theoretically contain randomly chosen nucleotides at each of the 12 positions, 
giving a total of 412 ≈ 1.7 × 107 possible barcodes, each appearing an equal number of times. In practice, 
the methods of oligonucleotide synthesis likely result in slightly different incorporation efficiencies of 
different nucleotides at each position29. In addition, the number of target molecules barcoded in our T 
cell samples is often within an order of magnitude of the number of available barcodes, resulting in a 
significant probability that the same barcode is used more than once (‘barcode clash’) (Fig. 3a). In order 
to assess the impact that this barcode clash might have on the observed barcode family sizes, we first sim-
ulated barcoding molecules from a large, uniformly distributed pool of available barcodes and measured 
the proportion of molecules that were uniquely barcoded (Fig. 3b). This value depends on the ratio of the 
number of available barcodes (size of the barcode pool) to the number of molecules to be barcoded. In 
these simulations we also measure the maximum observed barcode clash size (Fig. 3c), which in contrast 
also depends on the absolute number of available barcodes and molecules to be barcoded. These simu-
lations show that in our protocol (barcoding in the order of 106 molecules with 107 available barcodes) 
around 90% of molecules get a unique barcode and the maximum clash size is predicted to be below 4. 
Thus barcode clash is unable to account for the range in barcode family sizes we observe in our data.
It is likely that the pool of barcodes we have available for labelling is not exactly uniformly distributed, 
which could lead to increased barcode clash. We simulated the barcoding, amplification and sequenc-
ing protocol using normally or lognormally distributed barcode frequency distributions, but this had 
little effect on the observed barcode family size distributions when compared to uniquely barcoding 
every molecule or to the expected distribution if every initial molecule was represented equally in the 
post-PCR amplified pool (Fig. 3d). We also derived the empirical distribution of barcodes in our initial 
oligonucleotide pool (see Supplementary Information and Supplementary Fig. 3) and simulations using 
this distribution do not show a barcode family size distribution deviating far from the sampling dis-
tribution expected from a uniformly distributed amplified pool (Fig. 3e). The output of the barcoding, 
amplification and sequencing pipeline is therefore robust to the likely occurrence of barcode clash and 
non-uniform barcode frequencies.
Inherited differences in PCR efficiency are necessary to explain the observed diversity in 
barcode family size. The experimental pipeline involves amplification followed by subsampling for 
sequencing. There are two distinct sources of stochasticity in the pipeline. The subsampling of sequences 
from the PCR product for sequencing introduces one source of heterogeneity. In addition, PCR efficien-
cies of less than 100% can introduce non-uniformity resulting from the inherent stochasticity of the PCR 
process30. In order to examine how each of these two sources of heterogeneity, namely variable efficiency 
and sampling could affect observed barcode family size distributions we developed a PCR simulator in 
which molecules are barcoded, amplified and then sampled in silico. The simulator is outlined schemati-
cally in Fig. 4a. In its most basic implementation (modelling PCR as a straightforward branching process 
with no error) the simulator can perform a full simulation (labelling initial molecules, performing 15 
PCR cycles with efficiency 0.8, sampling and sequencing including sequencing error) on 105 initial mol-
ecules in approximately 12 seconds on a standard specification laptop (Fig. 4b). Introducing PCR error 
substantially increases the simulation time, although altering the error rate further does not alter sim-
ulation time. Parallelisation and cluster research computing platforms make PCR simulation including 
error of large numbers of initial molecules feasible.
The simulated barcode distributions (the number of molecules present after amplification that are 
derived from each initial molecule) at different efficiencies are shown in Fig. 4c. The introduction of less 
than 100% efficiency introduces some barcode family size heterogeneity as described previously30. This 
variation arises because, in every replication cycle, any individual molecule may or may not replicate with 
a probability determined by the overall efficiency. The substantial shoulder observed in the distributions 
correspond to molecules which fail to be replicated in the first cycle of PCR and hence are present at 
half the average number of copies. However, the heterogeneity caused by low efficiencies is averaged out 
over many molecules and the majority of barcode family sizes are within a factor of two of each other 
at the end of the PCR reaction.
We next examined the influence of subsampling. In order to sequence the PCR product, molecules 
from the amplified sample are diluted and introduced to the flow cell to anneal to complementary 
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capture oligonucleotides. This introduces heterogeneity into barcode numbers, which can be modelled 
by a Poisson distribution (as an approximation to a binomial distribution), scaled to account for the fact 
that we cannot count those barcodes with an observed family size of zero (a zero-truncated Poisson). 
In order to investigate the effects of sampling independently from those of PCR efficiency, we simulate 
samples taken from PCRs of 100% efficiency. The simulations were carried out at different ratios of 
number of sequenced molecules to initial molecules. The distributions obtained are compared in Fig. 4d 
to those observed from the Protocol A data. It is immediately obvious that our data from Protocol A 
does not belong to the same family as the simulated distributions (Fig. 4d). In order to obtain statistical 
support for this conclusion, we fitted the best Poisson distribution to each set of experimental data using 
maximum likelihood to select the Poisson parameters. A comparison of the optimum fitted Poisson to 
the data using chi squared test rejected the null hypothesis (p = 0). These results strongly suggest that 
these data were not Poisson distributed, and that the sampling process cannot account for the broad 
distribution observed.
We therefore tried to formulate variations of the branching process model of PCR that could explain 
the broad barcode family size distribution observed. For each model, the distribution of barcode fre-
quencies (Fig. 5) and the coefficient of variation of the barcode frequency (Supplementary Fig. 4) were 
compared between model and experimental data.
Figure 3. (a)Probability that no two molecules receive the same barcode (“barcode clash”) when labelled 
with random nucleotide barcodes of the indicated length. Dotted lines: number of molecules that can 
be labelled with a 50% chance of no barcode clash. (b) Proportion of molecules that receive a unique 
barcode when labelling is simulated with the indicated number of available barcodes, uniformly distributed. 
Number of molecules to be barcoded is expressed as a proportion of the number of available barcodes. 
Data shown is mean and standard deviation of 50 repeated simulations. (c) Maximum number of initial 
molecules that receive the same barcode when barcoding is simulated with the indicated number of available 
barcodes, uniformly distributed. Number of molecules being barcoded is indicated by colour, expressed as a 
proportion of the number of available barcodes. Data shown is mean and standard deviation of 50 repeated 
simulations. (d) Observed barcode size distribution after simulation of labelling 250,000 molecules from 
uniformly or non-uniformly distributed pools of 500,000 available barcodes, 10 cycles of PCR (efficiency 
0.5) and sampling 300,000 molecules from the amplified pool. Inset: distribution of available barcodes for 
non-uniform simulations (green: normal (restricted to values > 0), orange: lognormal). Data shown are 
mean and standard deviation of 10 repeated simulations. Grey dotted line: expected distribution if the 
sampled molecules were drawn from a uniformly distributed amplified pool, in which all molecules had 
been uniquely barcoded and amplified equally. (e) Observed barcode size distribution when the indicated 
numbers of initial molecules are barcoded from a pool of 412 potential barcodes with barcode availability 
distributed as predicted from empirical labelling events observed (Supplementary Information and 
Supplementary Fig. 3). 25 PCR cycles (efficiency 0.75) are simulated on labelled molecules and samples 
of 100,000 are selected from the amplified pool. Solid line: mean of 10 repeated simulations. Dashed line: 
expected distribution if the sampled molecules were drawn from a uniformly distributed amplified pool, in 
which all molecules had been uniquely barcoded and amplified equally.
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The starting point is a standard branching process model of PCR (‘model 1’) where the efficiency of 
the PCR (between 0 and 1) refers to the probability that a molecule will replicate successfully in a cycle. 
Using this model, we simulate PCR and sampling, and show that the resulting barcode family size dis-
tributions do not diverge significantly from the expected Poisson distribution regardless of the efficiency 
used (Fig. 5a). Next, a target degradation model (‘model 2’) was used. Model 2 is set up as for model 1, 
except that when a molecule fails to duplicate in a cycle there is a chance that it instead degrades and 
is no longer available to be amplified in later cycles of the PCR. Again, simulation of this model does 
not reproduce the large deviation from a Poisson distribution that is seen in our data (Supplementary 
Fig. 5a).
Figure 4. (a) Schematic of the PCR simulator software used in this study. The software includes adding 
barcodes to molecules (‘labelling’), PCR amplification with a specified number of cycles, efficiency model 
and error rate, and sampling and sequencing from the amplified pool. (b) Time taken to perform a 
full simulation, which includes initialisation, labelling initial molecules, PCR cycles (using a standard 
branching process model), sampling from the amplified pool and sequencing. Simulations are performed 
with the indicated PCR error rate (per base per cycle) and the given number of initial template molecules. 
Simulations consist of 15 cycles of PCR with efficiency 0.8, a sample size equal to the number of initial 
molecules being chosen from the amplified pool and sequencing with error rate 10−4. Data shown is the 
mean of 5 repeated simulations at each set of conditions, as measured on a 2.8 GHz Intel Core i7 MacBook 
Pro. (c) The distribution of the number of copies of each of 100,000 initial target molecules after 25 cycles of 
PCR at efficiencies of 0.85 (red), 0.9 (blue) or 0.95 (green). (d) The distribution of observed barcode family 
sizes (coloured lines) after simulating PCR cycles (25 cycles at 0.9 efficiency) on 100,000 initial molecules 
and then sampling from the amplified pool to select those molecules that are observed in the sequencer 
output. The number of molecules sequenced is expressed as a proportion (the ‘sample ratio’) of the number 
of initial molecules (100,000). The solid coloured lines are the mean of 5 repeated simulations, and the 
dashed coloured lines are the expected distribution (a zero truncated Poisson with parameter equal to the 
sample ratio) if the sample was drawn from a uniformly distributed pool (which would occur if every initial 
molecule was uniquely barcoded and amplified identically). The black solid line is a representative example 
of the barcode family size distribution observed in TCR sequencing data from healthy volunteer PBMC.
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Next, we introduce competition for resource, which affects the success rate of duplication of mol-
ecules. This abstract ‘resource’ covers, for example, the availability of dNTPs and primer in the PCR 
mixture, and the ability of the enzyme to process the molecules inside the time frame given in the PCR 
protocol. The first resource competition model (‘Model 3’) is one in which there is a fixed, constant 
amount of resource available and the probability that a molecule successfully replicates in a cycle is given 
by the number of molecules present at the start of the cycle divided by the amount of resource. As such, 
the efficiency of the reaction decreases through the cycles once the number of molecules present exceeds 
the capacity of the available resource to process all those molecules in one cycle. Figure 5b shows that 
this model cannot reproduce the spread of barcode family sizes we observe in the data. An alternative 
resource competition model (‘Model 4’) involves degradation of resource as it is used, at a given deg-
radation rate. This model is also unable to account for our observed barcode family size distributions 
(Supplementary Fig. 5b).
Instead of a constant efficiency across all molecules and all cycles, we imagine that in a given cycle 
some molecules are able to replicate more efficiently than others. For instance this variation may depend 
on the position of the molecule within the sample (which may affect e.g. proximity to primer) or the 
conformation of the molecule (which may affect ability of the primer to bind). We introduce a variable 
efficiency model (‘Model 5’), where the probability that a given molecule will replicate in a given cycle is 
chosen from a defined distribution. Model 5 is implemented using a normal distribution with a variety of 
parameters (Fig. 5c). A low mean efficiency and a large standard deviation produces the most divergence 
Figure 5. Observed barcode family size distributions observed under different models of PCR 
amplification. Simulations performed with 10,000 initial molecules, 25 cycles of PCR (with no error) and 
sequencing of 10,000 molecules selected from the amplified pool. Simulations were repeated 10 times and 
the mean and standard deviation are shown. The dotted lines represent the expected distribution if every 
initial molecule is barcoded uniquely and represented equally in the amplified pool. Grey and black lines 
represent the distributions observed experimentally in the indicated experiments. Models described in 
the text but not displayed here can be found in Supplementary Fig. 4. (a) Model 1: Standard branching 
process of PCR, with the indicated efficiencies. The efficiency is the probability that a given molecule 
will duplicate in a given cycle. (b) Model 3: Model of PCR where the duplication efficiency depends on 
competition between target molecules for a constant level of resource, given as a multiple of the number of 
initial molecules. (c) Model 5: Variable efficiency model of PCR, where the probability of a given molecule 
replicating in a given cycles is selected from a normal distribution (restricted to [0, 1]) with the indicated 
parameters (mean and standard deviation). (d) Model 6: Inherited efficiency model of PCR, where the 
probability of replication in a given cycle is identical for all molecules derived from the same initial 
molecule. The efficiencies for the initial molecules are selected from a normal distribution with the indicated 
parameters (mean and standard deviation). 25 PCR cycles are simulated on 10,000 initial molecules, and 
then a sample is drawn from the amplified pool at a multiple of 1 times or 2.5 times the number of initial 
molecules. The observed barcode family size distribution shown is the mean of 10 repeated simulations.
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from the expected barcode family size distribution, and is able to account for the majority of the spread 
seen in barcode family size observed in the KT2 data from Protocol B. However, none of the parameters 
investigated was able to reproduce the observed spread of family sizes observed in polyclonal or mono-
clonal data from Protocol A.
We adapted Model 5 to include the constraint that once efficiency is chosen for a molecule in cycle 
1 this same efficiency is inherited by all molecules produced from this initial molecule (‘Model 6’). 
Simulation of PCR and sampling using model 6 was performed, and showed that inherited efficiencies 
could produce a substantial amount of spread in the barcode family size distribution when the efficiency 
distribution has a low mean and a relatively large standard deviation (Fig.  5d). The observed barcode 
family size distribution from Model 6 can be seen to be broadly comparable to that seen in our exper-
imental data (from Protocol A) for these figures. In contrast, the distribution which arises from model 
5 is sufficient to account for most of the heterogeneity observed when using a fixed primer instead of 
ligating a primer to the end of the cDNA (Protocol B).
Discussion
PCR is a fundamental and ubiquitous tool of molecular biology laboratories. The combination of PCR 
and HTS, in particular, has driven an explosion in DNA sequence acquisition. In many of these appli-
cations, for example RNA-seq and lymphocyte antigen receptor repertoire studies, the quantification of 
transcripts is critical, since the output is based on counts of specific sequences. The avoidance of PCR 
bias is therefore critical and much effort has been expended on trying to control and mitigate bias. In 
this study, we examine the consistency of PCR amplification, using molecular barcodes to follow ampli-
fication of single molecules. We find that the distribution of the number of copies of an initial molecule 
that are observed in sequencer output varies over a wide range, even when primers, target sequence, bulk 
PCR conditions and barcode sequences are kept constant.
The differential binding properties of different primers, and secondary structure within target 
sequences are well-established causes of PCR biases. Multiplex PCRs, for example, frequently show dif-
ferent efficiencies for different primer/target combinations. This bias is a known confounder of T cell 
repertoire studies, for example. As a result, we and others16 have developed techniques that use various 
types of 5′ RACE, and thus can amplify with amplicon-independent primers. However, the variation in 
target sequence to be amplified is obviously a variable that cannot be avoided. In this study we therefore 
consider the extent to which amplification bias can be attributed to sequence variability. We compare 
the amplification of heterogeneous mixtures of alpha or beta T cell receptor chains (typically containing 
> 10^4 different sequences) with amplification of a monoclonal T cell receptor from a T cell clone (this 
clone in fact expresses more than one TCR chain, a common feature of T cells31). Unexpectedly, PCR 
amplification efficiency (measured by the number of observed molecules derived from a single ancestor) 
varies broadly, both for the polyclonal and monoclonal populations. Indeed the extent of variability is 
very similar, suggesting that the actual sequence of the TCR variable region is not the major cause of dif-
ferent amplification rates. Our results do not, of course, imply that all sequences will be amplified equally. 
Indeed the length of the target and the GC content are well known to influence PCR efficiency6. Rather 
our results suggest that even when amplifying relatively small amplicons (< 1 KB) whose sequences are 
all rather comparable, substantial variation remains. Some degree of heterogenous amplification of T and 
B cell receptors has been observed previously32–34, although these studies have not focused on analysis of 
the distribution of the variation, or its relationship to inherent stochasticity of the PCR process.
Our data suggest that the sequence of the ligated barcodes is not the cause of the observed differential 
amplification, since barcode family size is not correlated between experiments. Although previous studies 
have shown a small effect of sequence variability adjacent to the PCR primer on efficiency3, we have 
directly compared placing the random barcode sequences immediately next to the primer, or at a dis-
tance of six base pairs, and did not observe any significant difference in heterogeneity. Indeed it seemed 
a priori unlikely that if the variation cannot be attributed to differences between V region sequences 
it could be caused by 12 base pair barcodes. Additionally, analysis of the structure of the pool of the 
random barcodes that are used to label the initial molecules suggests that while there is potential for 
barcode ‘clashes’ (where the same barcode is chosen to label more than one initial molecule), these are 
not large enough or prevalent enough to be the reason for the large barcode family sizes observed. We 
do, however, present some theoretical and simulation results that can help to guide the size of barcode 
pool size in different scenarios. These results suggest that a barcode of 12 base pairs (providing in the 
order of 107 different sequences) is sufficient to label pools of DNA targets in the order of 106 molecules.
The bulk conditions in all the PCR reactions obviously cannot account for the intra-experimental 
variation. However, as discussed previously, PCR is by its nature a stochastic process since at each cycle 
a molecule will be either replicated or not replicated with some probability p, which will be less than 
1 for all reactions in which replication efficiency is not 100%. For example, the PCR efficiencies in our 
model system (which we have measured using qPCR on plasmid dilutions) are typically in the order of 
80–90%. Furthermore, it is possible that there is local heterogeneity in the PCR vessel itself: for example 
temperature gradients, or heterogeneity introduced by phase shifts at the plastic/liquid or liquid/gas 
surfaces. We therefore examined the implications of different models in detail using a branching process 
PCR simulator.
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Simulation demonstrated clearly that lower efficiencies, a range of efficiencies, competition and 
resource limitation can all introduce some variation in the predicted output of the PCR for different 
molecules. As might be predicted, the extent of variation increases with cycle number, and with low 
and more variable efficiencies. The goal of minimising the number of cycles, and maximising efficiency 
does therefore lower overall expected variance of product molecular counts. However, the extent of the 
variance due to these properties is limited and does not explain our observed results. The only model 
we considered that was able to produce substantial variance in output comparable to that observed in 
Protocol A (Fig. 1c,d, top) is an inherited efficiency model, where all molecules produced from an initial 
molecule retain the same efficiency though all cycles. This result, too, is related to well-known evolution-
ary theory where significant divergence can only occur when selection operates on the inherited prop-
erties of the individual. A clue to the cause of the observed heterogeneity is provided by the observation 
that it is reduced by omitting the 3′ single stranded ligation step, and instead using a fixed primer in the 
V region (Fig. 1d, middle and bottom panels). Since the length of the cDNA molecules produced may 
be variable, due to incomplete reverse transcription, variation in length or composition of the cDNA 
at the 3′ end may be sufficient to significantly alter PCR amplification efficiency. Thus for TCR or BCR 
repertoire sequence, both multiplex PCR and RACE protocols have the potential to introduce substantial 
heterogeneity in amplification efficiency, which will materially affect quantitative features of the observed 
repertoire, substantially increasing the range of clone sizes observed (Supplementary Fig. 2). Barcoding 
therefore becomes essential for accurate quantification of transcript number.
The observed heterogeneity can be ascribed to two stochastic processes, one deriving from sampling of 
the amplified product for sequencing and one deriving from inherent heterogeneity of the PCR reaction. 
The relative contribution of each can be observed by comparing the CV of a simulation with no PCR 
heterogeneity (Supplementary Fig. 4b, model 1) with the other models we have explored (Supplementary 
Fig. 4b, models 3,5 and 6). It is evident that for models that do not incorporate inherited efficiencies (i.e. 
models 3, 5) most of the variation can be attributed to sampling.
In conclusion, we consider the implications of our findings for the community routinely using PCR 
for quantitative analysis of RNA or DNA populations. The major lesson is that molecular barcoding pro-
vides an essential tool that can mitigate for the effects of PCR heterogeneity. This is especially important 
for studies whose primary output is the comparative quantification of many diverse nucleotide fragments 
within a mixture, such as repertoire analysis. In situations where single molecule barcoding is difficult, 
or not practical, every effort needs to be taken to maximise the efficiency of the PCR reactions and 
minimise the number of cycles. In the longer term, single molecule amplification-free DNA sequencers, 
which are currently in development, may remove the requirement for a PCR amplification step alto-
gether. In the meantime, it continues to be important to appreciate the inherent stochasticity of the PCR 
process, and its possible effects on quantitative aspects of molecular biology.
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